We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Gilead’s Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19

By HospiMedica International staff writers
Posted on 21 Apr 2020
Print article
Image: Gilead’s Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19  (Photo courtesy of Gilead Sciences)
Image: Gilead’s Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19 (Photo courtesy of Gilead Sciences)
A study by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases {(NIAID) Rockville, MD, USA} has found that early treatment with Gilead Sciences’ (Foster City, CA, USA) remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2. The study was designed to follow dosing and treatment procedures used for hospitalized COVID-19 patients being administered the experimental antiviral drug in a large, multi-center, clinical trial

The study involved two groups of six rhesus macaques, with one group receiving remdesivir and the other animals being served as an untreated comparison group. The scientists infected both the groups with SARS-CoV-2 and administered an intravenous dose of remdesivir to the treatment group after 12 hours, followed by a daily intravenous booster dose for the next six days. The scientists timed the initial treatment to occur shortly before the virus reached its highest level in the animals’ lungs.

The scientists examined all animals 12 hours after the initial treatment and found the six treated animals to be in significantly better health than the untreated group, with the trend continuing over the course of the seven-day study. One of the six treated animals exhibited mild breathing difficulty, whereas all the six untreated animals showed rapid and difficult breathing. The amount of virus found in the lungs of the animals in the treatment group was significantly than those in the untreated group, and SARS-CoV-2 caused less damage to the lungs of the treated animals than the untreated animals.

The scientists believe that the data supports initiating remdesivir treatment in COVID-19 patients as early as possible to achieve maximum treatment effect, although they have noted that while remdesivir helped prevent pneumonia, it did not reduce virus shedding by the animals.

Related Links:
Gilead Sciences
National Institute of Allergy and Infectious Diseases



Print article
Radcal

Channels

Surgical Techniques

view channel
Image: The NaoTrac CE-certified neurosurgical navigation robot has received TFDA approval (Photo courtesy of Brain Navi Biotechnology)

Neurosurgical Navigation Robot Combines AI and Machine Vision to Streamline Procedures

Amidst the increasing demand for minimally invasive surgery, neuro-navigation has become standard in neurosurgery worldwide. Currently, most navigation systems use a “vision-based optical tracking system”... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more

Business

view channel
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)

Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure

Capsule endoscopy is generally a non-invasive technique that enables complete examination of the gastrointestinal tract with the use of the disposable and wireless device known as the video capsule.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.